HEALTHCARE: FDA OK for Hydrus Microstent
Irvine-based Ivantis Inc., an 11-year-old ophthalmic device maker of eyelash-sized stents used to treat glaucoma, couldn’t pick a better time to bring its first product, Hydrus Microstent, to market in the U.S.
INNOVATION: VR firm gets local funding
“I wanted to take people to another world,” Spaces Inc. co-founder and Chief Executive Shiraz Akmal told the Business Journal at the preview event of its new Terminator VR experience: “Terminator Salvation: Fight for the Future.”
Latest Switch: Avelar Will Head R&D Team
Irvine-based Evolus Inc. (Nasdaq: EOLS), a medical aesthetics company that went public this year, continues to build out its management team under the direction of new Chief Executive David Moatazedi.
Newport Beach-based Concierge Key Health, which has created a mobile app for on-demand access to medical specialists, named Richard Afable as president and chief executive,
HEALTHCARE: Baronoff aims for more efficiency
Integration is task No. 1 for KPC Healthcare Inc.’s new chief executive, Peter Baronoff.
Supplement Maker’s Next Stop Turkey
Irvine-based supplement maker ChromaDex Corp. (Nasdaq: CDXC) is ramping up international expansion efforts.
INNOVATION: CEO drives web traffic with new locales
Chief Executive Adam Freede describes MadaLuxe Group’s e-commerce platform for its direct-to-consumer division, MadaLuxe Vault, like “a startup division with a more established company.”
HEALTHCARE: Plans to spend $20M for two trials
Novus Therapeutics Inc. (Nasdaq: NVUS) has its eyes—and ears—open for more funding.
Marwit Investment Management LLC has exited essentially all of its investments, giving Managing Partner Matthew Witte more time with family—including backing startups created by two of his kids.
Second in California With Hospital Birthing Center
There are basically two options for expecting mothers: obstetrician-gynecologists or midwives.
HEALTHCARE: Plans lawsuits to fight ‘false allegations’
The most awful thing for Brian Meshkin was the Federal Bureau of Investigation raiding Proove Biosciences Inc.’s Irvine headquarters and making “political theater about it” with media on-site.
San Clemente-based Rox Medical Inc. appointed Mike MacKinnon as chief executive. He came from Philips N.A. where he was head of sales for image guided technologies.
HEALTHCARE: Construction totals about $800 million
A third of the former “Big Three” senior housing real estate investment trusts is wearing a different color: HCP Inc. (NYSE: HCP) plans to slice its portfolio into three equal segments over the next few years.
HEALTHCARE: Says new valves should drive up Q4 sales
Recent stock reactions to Orange County’s largest publicly traded company speak to Edwards Lifesciences Corp.’s (NYSE: EW) second-quarter earnings.
Subsidiary Launches Behavioral Health Program
With the number of Americans 65 and older projected to outnumber children for the first time in U.S. history by 2030—census estimates show all baby boomers will be older than 65 then, expanding the size of the older population to 78 million—healthy aging is ever more important.
Irvine-based Biolase Inc. (Nasdaq: BIOL) on Aug. 8 named Todd Norbe president and chief executive.
HEALTHCARE: Commercial Expansion and Big Data Programs
The future of healthcare is moving towards precision, a.k.a., personalized medicine—and molecular diagnostics play an increasingly important role in one of the main components of precision medicine, gene-specific therapeutics.
Low-Cost Plan Not A Hit with Dentists
Net dental enrollment in dental HMO and PPO plans decreased more than 25% to about 2 million members in year through July.
Operators Still Hope for More Open Fed
Policy changes and medical marijuana go hand in hand, and for Danielle Piomelli, professor of anatomy and neurobiology at University of California- Irvine, true progress is only possible if the federal status of the drug is changed.
‘Really’ Wearables; Computer Best Practices
There’s no denying the healthcare of tomorrow won’t be limited to the four walls of a hospital and that technology will play a crucial role in enhancing the patient-centered model.
OC Trial Site Largest Of Nationwide Study
An oral form of insulin doesn’t exist yet, but Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) has announced it’s taking a major step toward attaining the Holy Grail of diabetes care.
Providers Turn to Tech to Control Costs
To HMO or PPO, that’s the question. Orange County’s top health maintenance organizations experienced growth in the former and decline in the latter during the 12 months through July.
Americans Forking Out Billions Out-of-Pocket
Healthcare is changing rapidly, pushed by the rise of a new breed of informed patient who is seeking alternatives to conventional treatments.
Design to ‘Real-World’ Trials; It’s a Value Play
Value-based care—the healthcare model designed to incentivize providers to improve patient recovery and reduce cost—is not news in California, an early adopter of the Affordable Care Act. The shift is also changing the approach to new-product adoption.
Masimo Corp. (Nasdaq: MASI) reported revenue of $211.6 million, including royalty, with product revenue for the second quarter totaling $202 million, up 12.4% compared to the same quarter a year ago.
Irvine-based Quality Systems Inc. (Nasdaq: QSII) reported $133.2 million in revenue for its latest quarterly results, a 1.7% year-over-year increase.
DentalXChange Debuts Credential Platform
Smile Brands Inc. is making a foray into Nevada in a partnership with Las Vegas-based P3 Dental Group.
HEALTHCARE: Funding release vote of confidence
Irvine-based LensGen Inc.’s recent $11 million funding, part of a $21 million Series A funding raised last May, represents a vote of confidence by investors.
HEALTHCARE: Appoints CFO, 3 others to leadership
Avid Bioservices Inc. (Nasdaq: CDMO) in Tustin reported fourth-quarter and fiscal-year results last week, marking year one of its remaking—a new name, business plan, management and board.
HEALTHCARE: Three drug trials, overactive bladder first
Orange County’s adding a pharmaceutical company to its ecosystem that walks quietly and carries a big wallet.
Ex-Astellas Execs Join Now-5-Member Board
Clinical-stage biopharmaceutical company Urovant Sciences Ltd. appointed Sef Kurstjens and Pierre Legault to its board of directors, increasing the number of members from three to five (see related story on page 1).
Evolus Inc. (Nasdaq: EOLS) priced an additional public offering of 4 million shares of common stock at $20 each. The offering consists of 3 million shares offered by the medical aesthetics company and a million shares offered by a selling stockholder.
Irvine-based Urovant Sciences Inc. is seeking $150 million via the public markets to extend clinical trials of therapies to treat urologic conditions.
HEALTHCARE: Sees FDA nod by year-end
The digestive system measures up to 30 feet long in adults, including the esophagus, stomach, small intestine, large intestine, liver and pancreas.
Ex-Abbott Laboratories Jeffrey Fecho Joins Firm
Endologix Inc. (Nasdaq: ELGX) needs to nail down product quality.
Medicine at OCTANe Ophthalmology event
Orange County again proved it’s the center for ophthalmology. Heavy hitters like Aerie Pharmaceuticals Inc., Alcon, Johnson & Johnson Vision, Carl Zeiss Meditec Inc. and Allergan PLC shared their perspectives at OCTANe’s annual Ophthalmology Technology Summit on June 29 at Fashion Island Hotel.
SJC Maker Avenu Said Its System Gives New Option
Don’t call it disruption.
Flagship Device Detects Heart Rhythm Disorders
ACS Diagnostics Inc. is moving into exciting, unchartered territory in ambulatory cardiac monitoring with its Food and Drug Administration-cleared CORE 12, which stands for cardiac outpatient real-time ECG.
STARTUPS: Hood kitchen doubles size, grows offerings
Innovation is the buzzword, but the entrepreneurial spirit isn’t limited to those with ideas for a company, but also unique incubation models.
Masimo Debuts Infrared Bluetooth Thermometer
The Food and Drug Administration approved the use of Medtronic PLC’s (NYSE: MDT) MiniMed 670G system in patients with Type 1 diabetes 7 years of age and older.
Female Incontinence Product Maker Seeks $3M
Incontinzence, or bladder leakage, is embarrassing, but not uncommon.
Meanwhile, More Board Tweaks to Help Reposition
In light of impending generic competition, Allergan PLC recently made the point that its eye care business is more than dry-eye drug Restasis.
HEALTHCARE: East Coast expansion will add 10,000 SF
Axis Research & Technologies is growing its footprint, starting with the July opening of a 10,000-square-foot facility in Columbia, Md.
The David and Molly Pyott Foundation gave a $1.7 million gift to Easterseals Southern California (ESSC).
Evolus Inc. named Michael Jafar chief marketing officer, a new position, and its second recent hire from the executive ranks of Allergan plc.
HEALTHCARE: Activists seek to unlock shareholder value
A letter from activist shareholders Appaloosa LP in Miami, Fla., and New York-based Senator Investment Group LP to Allergan PLC (NYSE: AGN) last week is a short-term blessing in disguise.
‘Pod’ Priced to Move, Used For Multiple Conditions
The Orange County medical device scene continues to bustle with activity.